Literature DB >> 16854829

Glaucoma screening during regular optician visits: can the population at risk of developing glaucoma be reached?

R Stoutenbeek1, N M Jansonius.   

Abstract

AIM: To determine the percentage of the population at risk of developing glaucoma, which can potentially be reached by conducting glaucoma screening during regular optician visits.
METHODS: 1,200 inhabitants aged >40 years were randomly selected from Dutch community population databases. A questionnaire was mailed to these inhabitants with questions on their latest optician visit and risk factors for glaucoma. A second questionnaire was sent to their opticians, who were asked about their willingness to conduct an additional glaucoma screening programme in the future.
RESULTS: The questionnaire was returned by 959 of 1,200 inhabitants and 37 of 50 opticians. The percentage of inhabitants who visited an optician during a 5-year period was 83% (95% confidence interval (CI) 80% to 85%). This percentage was adjusted for the presence of risk factors for glaucoma to obtain the percentage of the population at risk of developing glaucoma. The percentage of opticians willing to cooperate in a glaucoma screening programme extended beyond a non-contact tonometry measurement alone was 91% (95% CI 77% to 98%).
CONCLUSION: By conducting glaucoma screening during regular optician visits, a large section of the population at risk of developing glaucoma can be reached.

Entities:  

Mesh:

Year:  2006        PMID: 16854829      PMCID: PMC1857453          DOI: 10.1136/bjo.2006.095505

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Accuracy of glaucoma detection with frequency-doubling perimetry.

Authors:  J R Trible; R O Schultz; J C Robinson; T L Rothe
Journal:  Am J Ophthalmol       Date:  2000-06       Impact factor: 5.258

2.  Frequency doubling perimetry screening mode compared to the full-threshold mode.

Authors:  Remco Stoutenbeek; Govert P Heeg; Nomdo M Jansonius
Journal:  Ophthalmic Physiol Opt       Date:  2004-11       Impact factor: 3.117

3.  Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population.

Authors:  F C Hollows; P A Graham
Journal:  Br J Ophthalmol       Date:  1966-10       Impact factor: 4.638

4.  Refractive error and glaucoma.

Authors:  K Grødum; A Heijl; B Bengtsson
Journal:  Acta Ophthalmol Scand       Date:  2001-12

5.  Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study.

Authors:  Simone de Voogd; M Kamran Ikram; Roger C W Wolfs; Nomdo M Jansonius; Albert Hofman; Paulus T V M de Jong
Journal:  Ophthalmology       Date:  2005-09       Impact factor: 12.079

Review 6.  Primary open-angle glaucoma in blacks: a review.

Authors:  Lyne Racette; M Roy Wilson; Linda M Zangwill; Robert N Weinreb; Pamela A Sample
Journal:  Surv Ophthalmol       Date:  2003 May-Jun       Impact factor: 6.048

7.  Open-angle glaucoma and systemic hypertension: the blue mountains eye study.

Authors:  Paul Mitchell; Anne J Lee; Elena Rochtchina; Jie Jin Wang
Journal:  J Glaucoma       Date:  2004-08       Impact factor: 2.503

8.  Refractive errors, intraocular pressure, and glaucoma in a white population.

Authors:  Tien Yin Wong; Barbara E K Klein; Ronald Klein; Michael Knudtson; Kristine E Lee
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

9.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Bo Bengtsson; Leslie Hyman; Boel Bengtsson; Mohamed Hussein
Journal:  Arch Ophthalmol       Date:  2002-10

10.  Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis.

Authors:  S Bonovas; V Peponis; K Filioussi
Journal:  Diabet Med       Date:  2004-06       Impact factor: 4.359

View more
  1 in total

1.  Predicting undetected glaucoma according to age and IOP: a prediction model developed from a primarily European-derived population.

Authors:  Sigridur E Oskarsdottir; Anders Heijl; Boel Bengtsson
Journal:  Acta Ophthalmol       Date:  2018-10-15       Impact factor: 3.761

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.